Trump: US to Recommend Drugmakers Produce Smaller Vaccine Doses

The significance here is less about vaccine science than about the state's willingness to direct manufacturers' production formats and dosing schedules, and to carve out exemptions for children. That is a direct intervention into how pharmaceutical supply is configured, not a procurement or pricing matter, and it lands on drugmakers already navigating public-health expectations. Whether companies treat the recommendation as binding, and how pediatric exemption guidance is implemented, are the open questions worth watching.